Pyxis Oncology, Inc
Clinical trials sponsored by Pyxis Oncology, Inc, explained in plain language.
-
New drug duo takes on tough cancers
Disease control Recruiting nowThis study tests a new drug called PYX-201 combined with pembrolizumab (a standard immunotherapy) in people with advanced solid tumors that have not responded well to other treatments. The main goals are to find the safest dose and see if the combination can shrink tumors or slow…
Phase: PHASE1, PHASE2 • Sponsor: Pyxis Oncology, Inc • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New drug PYX-201 targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new drug called PYX-201 in people with advanced solid tumors that have come back or spread. The main goals are to find a safe dose and see if the drug can shrink tumors. About 330 adults with certain types of breast cancer, head and neck cancer, or …
Phase: PHASE1 • Sponsor: Pyxis Oncology, Inc • Aim: Disease control
Last updated May 12, 2026 13:42 UTC